MedPath

UNIVERSITY OF CINCINNATI

🇺🇸United States
Ownership
-
Established
1819-01-01
Employees
5.9K
Market Cap
-
Website
https://www.uc.edu/

Use of Thalidomide in Chronic Uveitis

Phase 4
Terminated
Conditions
Uveitis
First Posted Date
2006-04-14
Last Posted Date
2007-12-06
Lead Sponsor
University of Cincinnati
Target Recruit Count
15
Registration Number
NCT00314665
Locations
🇺🇸

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea

Phase 4
Completed
Conditions
Obstructive Sleep Apnea
First Posted Date
2006-03-28
Last Posted Date
2007-12-12
Lead Sponsor
University of Cincinnati
Target Recruit Count
100
Registration Number
NCT00307957
Locations
🇺🇸

University Ear, Nose and Throat Specialists, Cincinnati, Ohio, United States

🇺🇸

University of Indiana Medical Center, Indianapolis, Indiana, United States

🇺🇸

Department of OTO-HNS Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea

Phase 4
Completed
Conditions
Acid Reflux Disease
Obstructive Sleep Apnea
First Posted Date
2006-03-28
Last Posted Date
2007-12-12
Lead Sponsor
University of Cincinnati
Target Recruit Count
68
Registration Number
NCT00307944
Locations
🇺🇸

University Ear, Nose and Throat Specialists, Cincinnati, Ohio, United States

Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor

Not Applicable
Terminated
Conditions
Premature Birth
Premature Labor
Interventions
Drug: Oral Nifedipine or placebo
First Posted Date
2006-03-23
Last Posted Date
2009-11-09
Lead Sponsor
University of Cincinnati
Target Recruit Count
33
Registration Number
NCT00306462
Locations
🇺🇸

University Hospital, Cincinnati, Ohio, United States

Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)

Phase 3
Completed
Conditions
ADHD
Substance Abuse
Interventions
First Posted Date
2005-12-13
Last Posted Date
2013-06-07
Lead Sponsor
University of Cincinnati
Target Recruit Count
303
Registration Number
NCT00264797
Locations
🇺🇸

Gateway Community Services, Jacksonville, Florida, United States

🇺🇸

St. Luke's-Roosevelt Hospital, Child and Family Institute, New York City, New York, United States

🇺🇸

SSTAR of Rhode Island, North Kingstown, Rhode Island, United States

and more 9 locations

Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Phase 3
Completed
Conditions
ADHD
Smoking
Interventions
First Posted Date
2005-11-15
Last Posted Date
2012-09-17
Lead Sponsor
University of Cincinnati
Target Recruit Count
255
Registration Number
NCT00253747
Locations
🇺🇸

Mayo Clinic Nicotine Research Program, Rochester, Minnesota, United States

🇺🇸

VA New York Harbor Healthcare System, New York City, New York, United States

🇺🇸

Maryhaven, Inc., Columbus, Ohio, United States

and more 3 locations

Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial

Phase 1
Completed
Conditions
Stroke
First Posted Date
2005-11-09
Last Posted Date
2009-05-08
Lead Sponsor
University of Cincinnati
Target Recruit Count
94
Registration Number
NCT00250991
Locations
🇺🇸

University of California, Los Angeles, UCLA Medical Center, 10833 Le Conte Ave., Los Angeles, California, United States

🇺🇸

University of Pennsylvania, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, Pennsylvania, United States

🇺🇸

Mercy Hospital, Western Hills, 3131 Queen City Ave., Cincinnati, Ohio, United States

and more 16 locations

Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)

Phase 2
Completed
Conditions
Alcoholism
Alcohol Abuse
Interventions
Behavioral: Placebo + MI
First Posted Date
2005-11-07
Last Posted Date
2010-11-03
Lead Sponsor
University of Cincinnati
Target Recruit Count
200
Registration Number
NCT00249405
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Interventional Management of Stroke (IMS) II Study

Phase 2
Completed
Conditions
Stroke
First Posted Date
2005-10-25
Last Posted Date
2012-07-25
Lead Sponsor
University of Cincinnati
Target Recruit Count
81
Registration Number
NCT00243906
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder

Phase 3
Completed
Conditions
Bipolar I Disorder
First Posted Date
2005-10-04
Last Posted Date
2013-12-10
Lead Sponsor
University of Cincinnati
Target Recruit Count
30
Registration Number
NCT00232414
Locations
🇺🇸

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath